Cumberland Pharmaceuticals (CPIX) Other Operating Expenses (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Other Operating Expenses across 17 years of filings, most recently posting $8.2 million for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $8.2 million, up 23.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.4 million (up 11.37% YoY), and the FY2025 annual result was $29.8 million, changed N/A from the prior year.
• Other Operating Expenses came in at $8.2 million for Q1 2026 at Cumberland Pharmaceuticals, down from $9.5 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $10.8 million in Q4 2023 to a low of $6.4 million in Q3 2025.
• The 5-year median for Other Operating Expenses is $7.4 million (2023), against an average of $7.6 million.
• Across the five-year window, Other Operating Expenses surged 66.9% in 2023 and dropped 29.27% in 2024, its largest moves.
• Cumberland Pharmaceuticals' Other Operating Expenses stood at $6.5 million in 2022, then surged by 66.9% to $10.8 million in 2023, then decreased by 29.27% to $7.7 million in 2024, then increased by 23.57% to $9.5 million in 2025, then dropped by 12.85% to $8.2 million in 2026.
• The last three Other Operating Expenses figures came in at $8.2 million (Q1 2026), $9.5 million (Q4 2025), and $6.4 million (Q3 2025), per Business Quant data.